Conagra adds an ‘On Track’ badge on packaging for 26 of its Healthy Choice frozen meals that call out GLP-1 ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

GSK is moving out of its 635K SF footprint at 14200 Shady Grove Road, where it is the sole tenant, just before its lease ...

Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has bee ...

International drug giant GSK plc is moving its vaccine R&D and infectious disease teams to Cambridge from Maryland, and plans to expand its footprint here.

GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments.

GSK's vaccine for shingles prevention. This new syringe presentation is designed to simplify the administration process for healthcare providers by eliminating the need to mix a powder and liquid ...

Scientists are working to create a new cancer vaccine that could “detect the undetectable” and stop the disease up to 20 years before it has the chance to develop. Pharmaceutical giant GSK and ...

5 This European regulatory review follows the file acceptance by the US FDA on 8 January 2025 for the new prefilled syringe presentation, continuing GSK’s commitment to providing solutions to ...

In 2021, GSK and Oxford initiated the Institute of Molecular and Computational Medicine, which has been at the forefront of researching new medicines. Tony Wood, chief scientific officer at GSK ...